Results 31 to 40 of about 19,206,393 (242)

Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials: A Systematic Review and Meta-analysis.

JAMA Oncol, 2022
Key Points Question How do the alternative statistical tests MaxCombo and difference in restricted mean survival time compare with the log-rank test under nonproportional hazards using data from immuno-oncology trials?
Mukhopadhyay P, Ye J, Anderson KM, Roychoudhury S, Rubin EH, Halabi S, Chappell RJ.   +6 more
europepmc   +2 more sources

Long-Term Impact of D2 Lymphadenectomy during Gastrectomy for Cancer: Individual Patient Data Meta-Analysis and Restricted Mean Survival Time Estimation. [PDF]

Cancers (Basel)
Simple Summary Debate exists regarding the effect of D2 vs. D1 lymphadenectomy on long-term oncological outcomes after gastrectomy for cancer. The aim of our individual patient data meta-analysis was to assess the impact of D2 lymphadenectomy on long ...
Aiolfi A, Bona D, Bonitta G, Lombardo F, Manara M, Sozzi A, Schlanger D, Popa C, Cavalli M, Campanelli G, Biondi A, Bonavina L, OGSA Group for Esophagogastric Surgery.   +12 more
europepmc   +2 more sources

On the empirical choice of the time window for restricted mean survival time. [PDF]

Biometrics, 2020
The t‐year mean survival or restricted mean survival time (RMST) has been used as an appealing summary of the survival distribution within a time window [0, t].
Tian L, Jin H, Uno H, Lu Y, Huang B, Anderson KM, Wei LJ.   +6 more
europepmc   +2 more sources

Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation.

JACC: Heart Failure, 2020
OBJECTIVES The study sought to demonstrate the statistical and utilitarian properties of restricted mean survival time (RMST) and restricted mean time lost (RMTL) for assessing treatments for heart failure (HF) with reduced ejection fraction ...
C. Perego, M. Sbolli, C. Specchia, M. Fiuzat, Z. McCaw, M. Metra, Chiara Oriecuia, G. Peveri, Lee-Jen Wei, C. O’Connor, M. Psotka   +10 more
semanticscholar   +3 more sources

Restricted Mean Survival Time Analysis to Estimate SGLT2i-Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients With Type 2 Diabetes in Taiwan.

JAMA Netw Open, 2022
Key Points Question Is restricted mean survival time (RMST) analysis feasible to translate comparative cardiovascular and kidney outcomes of sodium-glucose cotransporter-2 inhibitor (SGLT2i) vs dipeptidyl peptidase-4 inhibitor (DPP4i) therapy in routine ...
Peng ZY, Yang CT, Kuo S, Wu CH, Lin WH, Ou HT.   +5 more
europepmc   +2 more sources

Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome [PDF]

BMC Medical Research Methodology, 2013
BackgroundDesigns and analyses of clinical trials with a time-to-event outcome almost invariably rely on the hazard ratio to estimate the treatment effect and implicitly, therefore, on the proportional hazards assumption.
P. Royston, M. Parmar
semanticscholar   +3 more sources

Analysis of the Single Ventricle Reconstruction Trial Using Restricted Mean Survival Time and Shunt Type Received [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Stephen J. Dolgner, Yuen L. Tjoeng, Titus Chan   +2 more
doaj   +2 more sources

Clinician's Approach to Advanced Statistical Methods: Win Ratios, Restricted Mean Survival Time, Responder Analyses, and Standardized Mean Differences. [PDF]

J Gen Intern Med
Lane M, Miao T, Turgeon RD.
europepmc   +2 more sources

Statistical Considerations for Sequential Analysis of the Restricted Mean Survival Time for Randomized Clinical Trials. [PDF]

Stat Biopharm Res, 2021
Lu Y, Tian L.
europepmc   +2 more sources

Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models

BMC Medical Research Methodology, 2021
Background Royston-Parmar flexible parametric survival models (FPMs) can be fitted on either the cause-specific hazards or cumulative incidence scale in the presence of competing risks.
Sarwar I. Mozumder, Mark J. Rutherford, Paul C. Lambert   +2 more
doaj   +1 more source